These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 2327765

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
    Beskid G, Siebelist J, McGarry CM, Cleeland R, Chan K, Keith DD.
    Chemotherapy; 1990; 36(2):109-16. PubMed ID: 2107064
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.
    Jones RN, Sanchez ML.
    Diagn Microbiol Infect Dis; 1994 Jan; 18(1):61-8. PubMed ID: 8026159
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.
    Barry AL, Fuchs PC.
    Antimicrob Agents Chemother; 1991 May; 35(5):955-60. PubMed ID: 1906696
    [Abstract] [Full Text] [Related]

  • 12. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS, Mazens-Sullivan MF, Bartlett RC.
    Chemotherapy; 1992 May; 38(5):308-18. PubMed ID: 1337507
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC, Chin NX, Neu NM.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-Brucella activity of Ro 23-9424, a dual-action antibacterial.
    Qadri SM, Ueno Y, Ayub A.
    Chemotherapy; 1993 Apr; 39(6):386-9. PubMed ID: 8222864
    [Abstract] [Full Text] [Related]

  • 17. RO 23-9424, a new cephalosporin 3'-quinolone: in-vitro antimicrobial activity and tentative disc diffusion interpretive criteria.
    Pfaller MA, Barry AL, Fuchs PC.
    J Antimicrob Chemother; 1993 Jan; 31(1):81-8. PubMed ID: 8444677
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro activity of OPC-17116.
    Neu HC, Fang W, Gu JW, Chin NX.
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1310-5. PubMed ID: 1329620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.